DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Samson SL, Sathyanarayana P, Jogi M. et al.
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial.
Diabetologia 2011;
54: 3093-3100
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.